Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline

Table 1

Summary of groups information.

Groups	Drug	Concentration	Administration	Volume
Group 1	Tigecycline	1 mg/mL	Topical	50 L	8
Group 2	Saline	0.9%	Topical	50 L	8
Group 3	Tigecycline	1 mg/mL	Subconjunctival	0.05 mL	8
Group 4	Saline	0.9%	Subconjunctival	0.05 mL	8